Home  /  Resource Library  /  Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: Three-year update of the ECHELON-1 study

Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: Three-year update of the ECHELON-1 study

ASCO 2019: Updated results of a phase III trial investigating Brentuximab Vedotin in combination with chemotherapy for first line treatment of Hodgkin lymphoma.